Black Diamond Therapeutics Inc (NASDAQ:BDTX) currently has a daily average trading volume of 3.43M but it saw 1453622 shares traded in last market. With a market cap of 127.94M USD, the company’s current market price of $2.25 came rising about 13.07 while comparing to the previous closing price of $1.99. In past 52 weeks, the stock remained buoying in the range of price level as high as $6.75 and as low as $1.20.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Raymond James which initiated the stock as “Outperform” in its note to investors issued on July 31, 2024, recommending a price target of $20 for it. Stifel issued its recommendations for the stock as it upgraded the price target for the stock in the range of between $2 and $10.
Over the week, BDTX’s stock price is moving 10.84% up while it is 40.62% when we observe its performance for the past one month. Year-to-date it is 5.14% up and over the past year, the stock is showing a downside performance of -53.99%.
The company is expected to be releasing its next quarterly report in June, for which analysts forecasted an EPS of -0.22 while estimate for next year EPS is 0.31.
Currently, Black Diamond Therapeutics Inc’s total number of outstanding shares is 56.68M with 0.62% of that held by the insiders while 84.14% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at 3.19% and return on equity (ROE) at 4.14%. It has a price to earnings ratio (P/E ratio) of 36.47. Stock’s beta reads 2.73. Stock has a price to book (P/B) ratio of 0.90 while price to sale or P/S ratio amounts to 1.83. Its return on asset (ROA) is 3.19% on average.
